← All organizations
Highest phase reached
Phase 3
First clinical trial
Apr 1, 2018Last known activity
Aug 31, 2021
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 3 trials)
Phase 3 (1 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (3)
- NCT05008939CollaboratorN/AAug 31, 2021
- NCT04292704CollaboratorN/ADec 13, 2019
- NCT03932136CollaboratorPhase 3Apr 1, 2018
Details
- Last known activity
- Aug 31, 2021